Medicare Shared Savings Program ACO – 2026

ACO Name and Location

Primary PartnerCare ACO Independent Practice Association, Inc.

Previous Legal Business Entity Name: Primary PartnerCare Associates IPA, Inc.

1010 Northern Boulevard, Suite 328

Great Neck, NY 11021

 

ACO Primary Contact

Primary Contact Name: Marion Davis, CEO

Primary Contact Phone Number: 516-233-2484

Primary Contact Email Address: mdavis@primarypartnercare.com

 

Disclaimer: The contents of this document do not have the force and effect of law and are not meant to bind the public in any way, unless specifically incorporated into a contract. This document is intended only to provide clarity to the public regarding existing requirements under the law. This communication material was prepared as a service to the public and is not intended to grant rights or impose obligations. It may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations, and other interpretive materials for a full and accurate statement of its contents.

 

Organizational Information

ACO Participants – 2026

ACO Participants ACO Participant in Joint Venture
Benjamin Z. Arbesfeld, MD, PC N
Ihor Magun MD N
Long Beach Family Medicine, PC N
Primary PartnerCare Physicians, PLLC N
Woo Sup Kim MD PC N
Long Island Family Medical PLLC N
Persaud Medical, PLLC N
South Island Family Medical LLC N

 

ACO Governing Body

Member First Name Member Last Name Member Title/Position Member’s Voting Power (Percentage) Membership Type ACO Participant Legal Business Name, if Applicable
Dr. Harry Jacob Director & Chief Executive Medical Officer 12.5% ACO Participant Representative Primary PartnerCare Physicians, PLLC
Dr. Gary Tollin Director 12.5% ACO Participant Representative Primary PartnerCare Physicians, PLLC
Lawrence Crafa Director & Treasurer 12.5% ACO Participant Representative Primary PartnerCare Physicians, PLLC
James Stallone Director 12.5% ACO Participant Representative Primary PartnerCare Physicians, PLLC
James DeBonet Director 12.5% Medicare Beneficiary Representative N/A
Ebenezer Odoom Director 12.5% ACO Participant Representative Primary PartnerCare Physicians, PLLC
Aretha Persaud Director 12.5% ACO Participant Representative Persaud Medical, PLLC
Marion Davis Director & Chief Executive Officer 12.5% Other N/A

Member’s voting power may have been rounded to reflect a total voting power of 100 percent
 

Key ACO Clinical and Administrative Leadership

ACO Executive: Marion Davis

Medical Director: Harry Jacob, MD

Compliance Officer: Charles Davis

Quality Assurance/Improvement Officer: James Stallone, DO

 

Associated Committees and Committee Leadership

Committee Name Committee Leader Name and Position
Quality Improvement James Stallone, DO, Chair
Medical Management Harry Jacob, MD, Chair
Credentialing/Recredentialing Harry Jacob, MD, Chair

 

Types of ACO Participants, or Combinations of Participants, that Formed the ACO:

  • Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Fourth Agreement Period
    • Performance Year 2026, N/A
    • Performance Year 2025, N/A
  • Third Agreement Period

    • Performance Year 2024, $4,350,809
    • Performance Year 2023, $5,822,908
    • Performance Year 2022, $6,060,262
    • Performance Year 2021, $5,209,182
    • Performance Year 2020, $4,911,631
  • Second Agreement Period

    • Performance Year 2019, $5,527,430
    • Performance Year 2018, $7,383,593
    • Performance Year 2017, $4,979,555
  • First Agreement Period

    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

 

Shared Savings Distribution

Performance Year Proportion invested in infrastructure Proportion invested in redesigned care processes/ resources Proportion of distribution to ACO participants
Fourth Agreement Period 2026 N/A N/A N/A
2025 N/A N/A N/A
Third Agreement Period 2024 35% 15% 50%
2023 35% 15% 50%
2022 35% 15% 50%
2021 35% 15% 50%
2020 35% 15% 50%
Second Agreement Period 2019 32% 18% 50%
2018 36% 14% 50%
2017 28% 22% 50%
First Agreement Period 2016 N/A N/A N/A
2015 N/A N/A N/A
2014 N/A N/A N/A

 

Quality Performance Results

2024 Quality Performance Results

Quality performance results are based on the CMS Web Interface collection type.

Measure # Measure Title Collection Type Performance Rate* Current Year Mean Performance Rate (Shared Savings Program ACOs)
001* Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) CMS Web Interface 3.70 9.44
134 Preventive Care and Screening: Screening for Depression and Follow-up Plan CMS Web Interface 96.76 81.46
236 Controlling High Blood Pressure CMS Web Interface 98.43 79.49
318 Falls: Screening for Future Fall Risk CMS Web Interface 96.15 88.99
110 Preventive Care and Screening: Influenza Immunization CMS Web Interface 89.46 68.60
226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS Web Interface 97.62 79.98
113 Colorectal Cancer Screening CMS Web Interface 96.19 77.81
112 Breast Cancer Screening CMS Web Interface 90.27 80.93
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS Web Interface 94.57 86.50
370 Depression Remission at Twelve Months CMS Web Interface 50.00 17.35
479* Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups Administrative Claims 0.1546 0.1517
484* Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions Administrative Claims 37.00
321 CAHPS for MIPS CAHPS for MIPS Survey 8.50 6.67
CAHPS-1 Getting Timely Care, Appointments, and Information CAHPS for MIPS Survey 87.79 83.70
CAHPS-2 How Well Providers Communicate CAHPS for MIPS Survey 96.04 93.96
CAHPS-3 Patient’s Rating of Provider CAHPS for MIPS Survey 93.68 92.43
CAHPS-4 Access to Specialists CAHPS for MIPS Survey 80.06 75.76
CAHPS-5 Health Promotion and Education CAHPS for MIPS Survey 65.49 65.48
CAHPS-6 Shared Decision-Making CAHPS for MIPS Survey 62.68 62.31
CAHPS-7 Health Status and Functional Status CAHPS for MIPS Survey 74.79 74.14
CAHPS-8 Care Coordination CAHPS for MIPS Survey 87.68 85.89
CAHPS-9 Courteous and Helpful Office Staff CAHPS for MIPS Survey 94.63 92.89
CAHPS-11 Stewardship of Patient Resources CAHPS for MIPS Survey 23.14 26.98

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

 

For previous years’ Financial and Quality Performance Results, please visit data.cms.gov

 

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • No, our ACO does not use the SNF 3-Day Rule Waiver.
  • Payment for Telehealth Services:
    • Yes, our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

Fraud and Abuse Waivers

Primary PartnerCare ACO Independent Practice Association, Inc. (“ACO”) is a Medicare Shared Savings Program ACO. The Secretary of the Department of Health and Human Services has provided four waivers of federal fraud and abuse laws in connection with the Medicare Shared Savings Program. The ACO Board of Directors has made a bona fide determination that an arrangement with Quest Diagnostics as described below is reasonably related to the purpose of the Medicare Shared Savings Program, and has authorized such arrangement. The collaboration is related to the purposes of the Medicare Shared Savings Program because it promotes accountability for the quality, cost and overall care for a Medicare population by managing and coordinating care for Medicare beneficiaries, and encouraging investment in infrastructure and redesigned care processes for high quality and efficient service delivery for Medicare beneficiaries. Specifically, ACO is seeking ACO Participation Waiver protection for its arrangement with Quest Diagnostics to:

  • Promote evidence-based medicine and patient engagement
  • Meet the requirements for reporting quality and cost measures coordinating care
  • Establish clinical and administrative systems
  • Meet the clinical integration requirements of the Medicare Shared Savings Program
  • Evaluate the health needs of the ACO’s aligned population
  • Communicate clinical knowledge and evidence based medicine to Medicare beneficiaries
  • Develop standards for beneficiary access and communication, including beneficiary access to medical records

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800 MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048.